Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline reco

GUIDELINE TITLE
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations.

BIBLIOGRAPHIC SOURCE(S)
Flemming J, Madarnas Y, Franek J, Breast Cancer Disease Site Group. Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations. Toronto (ON): Cancer Care Ontario Program in Evidence-based Care; 2008 Sep 25. 42 p. (Evidence-based series; no. 1-13). [85 references]
GUIDELINE STATUS
This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.

abrir aquí para acceder al documento completo:
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline reco